University of Central Florida chemistry professor’s low-tech process for breaking down raw materials into sugar may be the linchpin for making low cost biofuels. Thor Renewable Energy Inc. has secured an exclusive license to the technology and plans to expand its commercial-scale biofuel production facilities to Florida’s Space Coast later this year. ..
Read More ⇒The Scripps Research Institute and OPKO Health, Inc. (NYSE: OPK) today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson’s disease. ..
Read More ⇒National Academy of Inventors and US Patent and Trademark Office to work closely to promote American academic innovation. ..
Read More ⇒The Florida Institute for the Commercialization of Public Research has appointed entrepreneur Jamie Grooms as its chief executive officer. Grooms has been a co-founder of two successful University of Florida spin-off companies, RTI Biologics (Nasdaq: RTIX) and Axogen Inc. ..
Read More ⇒The University of Florida is seeking companies interested in commercializing a metal catalyst that will facilitate cost-effective water oxidation to promote hydrogen's widespread use as an alternative fuel source. ..
Read More ⇒Tom O'Neal oversees GrowFL, which aids "second-stage" businesses. Since 2009, the program has helped create more than 1,400 jobs at 300-plus companies. ..
Read More ⇒Stephen A. Miller and his team have invented a biodegradable plastic that can be used to replace petroleum-based shopping bags, beverage bottles and other items. ..
Read More ⇒Building on a break-out inaugural year, the 2012 Florida Companies to Watch awards program returns to give second-stage businesses throughout Florida another opportunity to join a group of nationally recognized Companies to Watch honorees. This program celebrates growing second-stage companies headquartered in Florida and is presented by the Florida Economic Gardening Institute at the University of Central Florida, in association with the Edward Lowe Foundation. ..
Read More ⇒OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that it has completed a major Licensing and Collaboration Agreement with The Moffitt Cancer Center, the only National Cancer Institute (NCI) Comprehensive Cancer Center in Florida. The agreement provides OvaGene with exclusive worldwide rights to develop and commercialize proprietary microRNA-based assays that predict drug response for currently used cancer treating drugs. The proprietary assays were developed and validated at the Moffitt Cancer Center under the leadership of Dr. Johnathan Lancaster, a world renowned scientist and clinician specializing in Women's Cancers. ..
Read More ⇒The Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with NanoPhotonica, an early-stage Orlando-based company that develops nanomaterials for next generation video displays, solar cells, and a range of other photoelectric devices. The Institute works with Florida's research universities and institutions to support new company and job creation. The goal of this program is to bridge funding gaps for early-stage companies and enable them to attract additional capital from angels, venture capital firms and others. ..
Read More ⇒
